Found 4 matching trials
Expanded Access Program for GBM Subjects N/A This small-size patient population expanded access program is to provide ac...
Show More Location
Brigham & Women's Hospital
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma PHASE1 This study is to evaluate the safety, tolerability, efficacy and immunogeni...
Show More Location
Pusan National University Yangsan Hospital
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma PHASE1 This is first in human study to evaluate the safety, tolerability, immunoge...
Show More Status
Active Not Recruiting
Location
Samsung Medical Center
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma PHASE1 This is a Phase 1/2a, open-label study to evaluate the safety, tolerability...
Show More Location
The Catholic University of Korea, Incheon St. Mary's Hospital
Learn More & Join Trial